Security key
86889P208
Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (SRZN)
CUSIP: 86889P208
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 4,529,305
- Total 13F value
- $40,492,894
- Share change
- +581,657
- SEC-reported price per share
- $8.94
- Number of holders
- 30
- Value change
- +$5,077,667
- Number of buys
- 11
- Number of sells
- 5
- Shares outstanding
- 13,053,283
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
30
Top holders
10
SRZN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Surrozen, Inc./DE SEC filings
Surrozen, Inc./DE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86889P208
Recent filing periods:
Ownership snapshot
Top reported holders of SRZN - Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AI Biotechnology LLC
Disclosed value leader
AI Biotechnology LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: AI Biotechnology LLC
Showing 1-6 of 15 holder rows.
Quick read
AI Biotechnology LLC leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AI Biotechnology LLC's linked filing trail.
Comparable ownership
Top 5
AI Biotechnology LLC
9.9%
Nantahala Capital Partners Limite...
2.2%
PERCEPTIVE ADVISORS LLC
1.9%
Alyeska Investment Group, L.P.
0.8%
DRIEHAUS CAPITAL MANAGEMENT LLC
0.79%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AI Biotechnology LLC |
13D/G
|
9.9%
|
$8,462,521
844,563 shares
|
$0 | 24 Mar 2025 |
| Nantahala Capital Partners Limited Partnership |
13D/G
|
2.2%
|
$740,658
73,918 shares
|
-$1,032,581 | 31 Mar 2025 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
1.9%
|
$1,669,993
166,666 shares
|
$0 | 31 Mar 2025 |
| Alyeska Investment Group, L.P. |
13D/G
13F
Company
|
0.8%
|
$269,087
26,855 shares
|
$0 | 31 Dec 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
13D/G
Company
|
0.79%
from 13D/G
|
$2,389,530
204,934 shares
|
— | 31 Mar 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
5.2%
|
$7,918,656
679,130 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
30
Shares
4,529,305
Rows available
30
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
29
Q2 2025 holders
30
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend